CCND1 and breast carcinoma: The majority of studies at the cell level found that BCAR3 promotes breast cancer progression through the development of estrogen resistance [5], promotion of CCND1 expression [6], promotion of migration and invasion [7, 16], and regulation of adhesion signaling [10].